Who can use Ongentys(Opicapone)?

A description of the medical conditions for which the drug is approved.

Therapeutic Use

ONGENTYS is indicated as an adjunctive therapy to levodopa/carbidopa for patients diagnosed with Parkinson's disease who are experiencing "off" episodes. These episodes are characterized by the return of Parkinsonian symptoms despite medication. It is specifically used to reduce the duration of these "off" periods and is intended for use in conjunction with the standard levodopa/carbidopa regimen.

Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in Parkinson's disease.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved